Safety and Early Efficacy of iPSC-Derived Motor Neuron Progenitor Cells (XS228) in Subacute Spinal Cord Injury: A Phase I Trial

Clinical trial NCT06976229 · RECRUITING

Trial details

NCT number: NCT06976229
Sponsor: XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Spinal Cord Injury Safety Clinical Trials Efficacy Induced Pluripotent Stem Cells Human Motor Neuron Progenitor Transplantation

Start date: 2025-07-02
Primary completion: 2028-02-21
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.